323 filings
Page 4 of 17
UPLOAD
RVLPQ
RVL Pharmaceuticals plc
20 Apr 23
Letter from SEC
12:00am
PRE 14A
RVLPQ
RVL Pharmaceuticals plc
Preliminary proxy
12 Apr 23
4:05pm
10-K
2022 FY
RVLPQ
RVL Pharmaceuticals plc
Annual report
20 Mar 23
5:19pm
8-K
RVLPQ
RVL Pharmaceuticals plc
20 Mar 23
RVL Pharmaceuticals plc Reports Fourth Quarter and Full Year 2022 Financial Results; Provides Commercial Update
7:06am
8-K
RVLPQ
RVL Pharmaceuticals plc
10 Mar 23
Regulation FD Disclosure
4:30pm
CT ORDER
RVLPQ
RVL Pharmaceuticals plc
8 Mar 23
Confidential treatment order
11:22am
EFFECT
RVLPQ
RVL Pharmaceuticals plc
7 Feb 23
Notice of effectiveness
12:15am
CORRESP
RVLPQ
RVL Pharmaceuticals plc
2 Feb 23
Correspondence with SEC
12:00am
UPLOAD
RVLPQ
RVL Pharmaceuticals plc
1 Feb 23
Letter from SEC
12:00am
4
RVLPQ
RVL Pharmaceuticals plc
30 Jan 23
RVL Pharmaceuticals / David F Burgstahler ownership change
5:29pm
4
RVLPQ
RVL Pharmaceuticals plc
30 Jan 23
RVL Pharmaceuticals / Sriram Venkataraman ownership change
5:28pm
4
Avista Healthcare Partners, L.P.
30 Jan 23
Change in insider ownership
5:27pm
SC 13D/A
RVLPQ
RVL Pharmaceuticals plc
30 Jan 23
RVL Pharmaceuticals / Avista Healthcare Partners GP ownership change
5:23pm
S-3
RVLPQ
RVL Pharmaceuticals plc
Shelf registration
27 Jan 23
4:10pm
4
RVLPQ
RVL Pharmaceuticals plc
26 Jan 23
RVL Pharmaceuticals / Christopher Klein ownership change
5:16pm
4
Schaub James
26 Jan 23
RVL Pharmaceuticals / James Schaub ownership change
5:15pm
8-K
RVLPQ
RVL Pharmaceuticals plc
9 Jan 23
RVL Pharmaceuticals plc Announces Preliminary Fourth Quarter Sequential Growth of 21% and Full Year 2022 UPNEEQ® Net Product Sales
7:03am
10-Q
2022 Q3
RVLPQ
RVL Pharmaceuticals plc
Quarterly report
10 Nov 22
4:59pm
8-K
RVLPQ
RVL Pharmaceuticals plc
10 Nov 22
RVL Pharmaceuticals plc Reports Third Quarter 2022 Financial Results; Provides Commercial Update
4:15pm
8-K
RVLPQ
RVL Pharmaceuticals plc
18 Oct 22
RVL Pharmaceuticals plc Announces Preliminary Third Quarter 2022 UPNEEQ® Net Product Sales
7:11am